Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Hemophagocytic Lymphohistiocytosis | Case Report

Hemophagocytic lymphohistiocytosis and histiocytic necrotizing lymphadenitis secondary to hemodialysis catheter-related bloodstream infection caused by Corynebacterium Striatum

Authors: ZhiPeng Zhao, Jing Li, Liu Yang, GuangWei Ren, LiHong Zhang, Tao Wang

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

We herein described the coexistence of hemophagocytic lymphohistiocytosis (HLH) and histiocytic necrotizing lymphadenitis, alternatively known as the Kikuchi disease (KD), secondary to hemodialysis catheter-related bloodstream infection (BSI) caused by Corynebacterium striatum.

Case presentation

A patient on maintenance hemodialysis had developed persistent fever and Corynebacterium striatum was subsequently identified from the culture of both catheter tip and peripheral blood. During mitigation of the BSI, however, his fever was unabated and ensuing workup further found thrombocytopenia, hyperferritinemia, hypertriglyceridemia, low NK cell activity and a surge in serum CD25 levels. Moreover, biopsy of the bone marrow and lymph node detected histopathological evidence of hemophagocytosis and KD, respectively. Upon these abnormalities, the title-bound diagnosis was considered and the patient was eventually recovered from the treatment of dexamethasone instead of antibiotics. Consistently, aberrations in his serum CD25 levels and NK cell activity had subsided two months after discharge.

Conclusions

Arguably, this encounter offered a unique chance to unravel the principal pathogenic cascade in immunobiology that made the three entities one disease continuum. As such, our work may add new understandings of HLH and/or KD secondary to severe infections in general and excessive release of cytokines in particular among patients with kidney diseases. The resultant early diagnosis is crucial to initiate appropriate treatment and improve the survival of patients with these challenging and potentially life-threatening disorders.
Literature
1.
go back to reference Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–16.CrossRefPubMed Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–16.CrossRefPubMed
2.
go back to reference Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814–22.CrossRefPubMedPubMedCentral Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814–22.CrossRefPubMedPubMedCentral
3.
go back to reference Duan W, Xiao ZH, Yang LG, Luo HY. Kikuchi’s disease with hemophagocytic lymphohistiocytosis: a case report and literature review. Med (Baltimore). 2020;99:e23500.CrossRef Duan W, Xiao ZH, Yang LG, Luo HY. Kikuchi’s disease with hemophagocytic lymphohistiocytosis: a case report and literature review. Med (Baltimore). 2020;99:e23500.CrossRef
4.
go back to reference Lim GY, Cho B, Chung NG. Hemophagocytic lymphohistiocytosis preceded by Kikuchi disease in children. Pediatr Radiol. 2008;38:756–61.CrossRefPubMed Lim GY, Cho B, Chung NG. Hemophagocytic lymphohistiocytosis preceded by Kikuchi disease in children. Pediatr Radiol. 2008;38:756–61.CrossRefPubMed
5.
go back to reference Soy M, Atagündüz P, Atagündüz I, Sucak GT. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2021;41:7–18.CrossRefPubMed Soy M, Atagündüz P, Atagündüz I, Sucak GT. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2021;41:7–18.CrossRefPubMed
6.
go back to reference Toda M, Fujii K, Yoshifuji A, et al. Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients. Clin Exp Nephrol. 2022;26:75–85.CrossRefPubMed Toda M, Fujii K, Yoshifuji A, et al. Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients. Clin Exp Nephrol. 2022;26:75–85.CrossRefPubMed
8.
go back to reference Anandh U, Johari S, Vaswani B. Hemophagocytic lymphohistiocytosis secondary to hemodialysis catheter-related blood stream infection. Indian J Nephrol. 2017;27:133–5.CrossRefPubMedPubMedCentral Anandh U, Johari S, Vaswani B. Hemophagocytic lymphohistiocytosis secondary to hemodialysis catheter-related blood stream infection. Indian J Nephrol. 2017;27:133–5.CrossRefPubMedPubMedCentral
9.
go back to reference Silva-Santana G, Silva CMF, Olivella JGB, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976–2020. Arch Microbiol. 2021;203:1863–80.CrossRefPubMedPubMedCentral Silva-Santana G, Silva CMF, Olivella JGB, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976–2020. Arch Microbiol. 2021;203:1863–80.CrossRefPubMedPubMedCentral
10.
go back to reference Garcia CM, McKenna J, Fan L, Shah A. Corynebacterium striatum bacteremia in end-stage renal disease: a case series and review of literature. R I Med J (2013). 2020;103:46–9.PubMed Garcia CM, McKenna J, Fan L, Shah A. Corynebacterium striatum bacteremia in end-stage renal disease: a case series and review of literature. R I Med J (2013). 2020;103:46–9.PubMed
11.
go back to reference Schick J, Etschel P, Bailo R, et al. Toll-like receptor 2 and mincle cooperatively sense corynebacterial cell wall glycolipids. Infect Immun. 2017;85:e00075–17.CrossRefPubMedPubMedCentral Schick J, Etschel P, Bailo R, et al. Toll-like receptor 2 and mincle cooperatively sense corynebacterial cell wall glycolipids. Infect Immun. 2017;85:e00075–17.CrossRefPubMedPubMedCentral
12.
go back to reference Peel MM, Palmer GG, Stacpoole AM, Kerr TG. Human lymphadenitis due to Corynebacterium pseudotuberculosis: report of ten cases from Australia and review. Clin Infect Dis. 1997;24:185–91.CrossRefPubMed Peel MM, Palmer GG, Stacpoole AM, Kerr TG. Human lymphadenitis due to Corynebacterium pseudotuberculosis: report of ten cases from Australia and review. Clin Infect Dis. 1997;24:185–91.CrossRefPubMed
13.
go back to reference Arceci RJ. When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr Opin Hematol. 2008;15:359–67.CrossRefPubMed Arceci RJ. When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr Opin Hematol. 2008;15:359–67.CrossRefPubMed
14.
go back to reference Damoiseaux J. The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor. Clin Immunol. 2020;218:108515.CrossRefPubMed Damoiseaux J. The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor. Clin Immunol. 2020;218:108515.CrossRefPubMed
15.
go back to reference Lin M, Park S, Hayden A, et al. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol. 2017;96:1241–51.CrossRefPubMed Lin M, Park S, Hayden A, et al. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol. 2017;96:1241–51.CrossRefPubMed
16.
go back to reference Katsuya H, Shimokawa M, Ishitsuka K, et al. Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma. Blood. 2017;130:39–47.CrossRefPubMed Katsuya H, Shimokawa M, Ishitsuka K, et al. Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma. Blood. 2017;130:39–47.CrossRefPubMed
17.
go back to reference Lin YW, Horiuchi H, Ueda I, Nambu M. Recurrent hemophagocytic lymphohistiocytosis accompanied by Kikuchi’s disease. Leuk Lymphoma. 2007;48:2447–51.CrossRefPubMed Lin YW, Horiuchi H, Ueda I, Nambu M. Recurrent hemophagocytic lymphohistiocytosis accompanied by Kikuchi’s disease. Leuk Lymphoma. 2007;48:2447–51.CrossRefPubMed
19.
go back to reference Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.CrossRefPubMed Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.CrossRefPubMed
20.
go back to reference Kumar G, Hererra M, Patel D, Nanchal R, Guddati AK. Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015. Am J Blood Res. 2020;10:330–8.PubMedPubMedCentral Kumar G, Hererra M, Patel D, Nanchal R, Guddati AK. Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015. Am J Blood Res. 2020;10:330–8.PubMedPubMedCentral
21.
go back to reference Bitencourt L, Pedrosa AL, de Brito SBCS, et al. COVID-19 and Renal Diseases: an update. Curr Drug Targets. 2021;22:52–67.CrossRefPubMed Bitencourt L, Pedrosa AL, de Brito SBCS, et al. COVID-19 and Renal Diseases: an update. Curr Drug Targets. 2021;22:52–67.CrossRefPubMed
22.
Metadata
Title
Hemophagocytic lymphohistiocytosis and histiocytic necrotizing lymphadenitis secondary to hemodialysis catheter-related bloodstream infection caused by Corynebacterium Striatum
Authors
ZhiPeng Zhao
Jing Li
Liu Yang
GuangWei Ren
LiHong Zhang
Tao Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03356-2

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.